Dr Briand is CNRS Research Director at the ‘Immunologie et chimie thérapeutiques’ unit of the Centre National de la Recherche Scientifique, the largest scientific research institution in France. He is co-inventor of Lupuzor and Nucant molecules (ImmuPharma’s anticancer programme). He has extensive industry experience in peptide chemistry and synthesis in Peninsula, USA and was also a founder of Neosystem, now Polypeptide-France, a leading peptide development and manufacturing company. Dr Briand is CNRS Research Director at the ‘Immunologie et chimie thérapeutiques’ unit of the Centre National de la Recherche Scientifique, the largest scientific research institution in France. He is co-inventor of Lupuzor and Nucant molecules (ImmuPharma’s anticancer programme). He has extensive industry experience in peptide chemistry and synthesis in Peninsula, USA and was also a founder of Neosystem, now Polypeptide-France, a leading peptide development and manufacturing company.

Radiology, Oncology, Cancer research